Georg Semmler
@georg-semmler.bsky.social
Medical University of Vienna & Center for Liver Research @ Odense University Hospital
Reposted by Georg Semmler
📰Disease-modifying effect of efruxifermin in compensated cirrhosis due to MASH: To miss the forest for the tree(s)
👉Cirrhosis regression only partially captures the potential therapeutic benefit of disease-modifying drugs in phase 3
🖇️ for explanation: authors.elsevier.com/sd/article/S...
👉Cirrhosis regression only partially captures the potential therapeutic benefit of disease-modifying drugs in phase 3
🖇️ for explanation: authors.elsevier.com/sd/article/S...
October 3, 2025 at 7:06 AM
📰Disease-modifying effect of efruxifermin in compensated cirrhosis due to MASH: To miss the forest for the tree(s)
👉Cirrhosis regression only partially captures the potential therapeutic benefit of disease-modifying drugs in phase 3
🖇️ for explanation: authors.elsevier.com/sd/article/S...
👉Cirrhosis regression only partially captures the potential therapeutic benefit of disease-modifying drugs in phase 3
🖇️ for explanation: authors.elsevier.com/sd/article/S...
Reposted by Georg Semmler
Thirteen years ago when I was still an M.D. student, I was invited for my first oral presentation at an @easlnews.bsky.social event.
🙏 to EASL for inspiration, education & support throughout this journey as well as to my mentors & friends! @bavenocoop.bsky.social #LiverSky
🙏 to EASL for inspiration, education & support throughout this journey as well as to my mentors & friends! @bavenocoop.bsky.social #LiverSky
May 7, 2025 at 2:04 PM
Thirteen years ago when I was still an M.D. student, I was invited for my first oral presentation at an @easlnews.bsky.social event.
🙏 to EASL for inspiration, education & support throughout this journey as well as to my mentors & friends! @bavenocoop.bsky.social #LiverSky
🙏 to EASL for inspiration, education & support throughout this journey as well as to my mentors & friends! @bavenocoop.bsky.social #LiverSky
Reposted by Georg Semmler
A huge thank you to all the Friends of the Young Talent Group joining today’s meeting in Vienna! As young voices shaping the future of GI, your involvement makes a real difference!
@annemariegrima.bsky.social @hannasternby.bsky.social
#myUEGcommunity
@annemariegrima.bsky.social @hannasternby.bsky.social
#myUEGcommunity
April 8, 2025 at 1:30 PM
A huge thank you to all the Friends of the Young Talent Group joining today’s meeting in Vienna! As young voices shaping the future of GI, your involvement makes a real difference!
@annemariegrima.bsky.social @hannasternby.bsky.social
#myUEGcommunity
@annemariegrima.bsky.social @hannasternby.bsky.social
#myUEGcommunity
Reposted by Georg Semmler
Can we please take a moment and congratulate my colleague
@georg-semmler.bsky.social with publication of his study on Tangier disease, an extremely rare disease caused by ABCA1 defect with no existing treatment?
Great journey with lipidomids & metabolomics of TD 🧪
academic.oup.com/jcem/advance...
@georg-semmler.bsky.social with publication of his study on Tangier disease, an extremely rare disease caused by ABCA1 defect with no existing treatment?
Great journey with lipidomids & metabolomics of TD 🧪
academic.oup.com/jcem/advance...
March 5, 2025 at 10:27 AM
Can we please take a moment and congratulate my colleague
@georg-semmler.bsky.social with publication of his study on Tangier disease, an extremely rare disease caused by ABCA1 defect with no existing treatment?
Great journey with lipidomids & metabolomics of TD 🧪
academic.oup.com/jcem/advance...
@georg-semmler.bsky.social with publication of his study on Tangier disease, an extremely rare disease caused by ABCA1 defect with no existing treatment?
Great journey with lipidomids & metabolomics of TD 🧪
academic.oup.com/jcem/advance...
Reposted by Georg Semmler
It was a great honor and experience to serve on a PhD committee of now PhDr. Kamilla Hejn of @ravnskjaer-lab.bsky.social together with Prof. @joannakalucka.bsky.social and @SorenFiskerSchmidt.
also happy to meet up with @georg-semmler.bsky.social during his sabbatical in 🇩🇰 @majathiele.bsky.social
also happy to meet up with @georg-semmler.bsky.social during his sabbatical in 🇩🇰 @majathiele.bsky.social
March 4, 2025 at 6:49 PM
It was a great honor and experience to serve on a PhD committee of now PhDr. Kamilla Hejn of @ravnskjaer-lab.bsky.social together with Prof. @joannakalucka.bsky.social and @SorenFiskerSchmidt.
also happy to meet up with @georg-semmler.bsky.social during his sabbatical in 🇩🇰 @majathiele.bsky.social
also happy to meet up with @georg-semmler.bsky.social during his sabbatical in 🇩🇰 @majathiele.bsky.social
Reposted by Georg Semmler
New from us: Screening for advanced fibrosis due to MASLD in T2D - the SCANDIA study. Out now in @LancetGastroHep:
authors.elsevier.com/a/1kFtR8nByr...
What did we do and find? Summarized in this thread:
authors.elsevier.com/a/1kFtR8nByr...
What did we do and find? Summarized in this thread:
authors.elsevier.com
December 13, 2024 at 5:50 AM
New from us: Screening for advanced fibrosis due to MASLD in T2D - the SCANDIA study. Out now in @LancetGastroHep:
authors.elsevier.com/a/1kFtR8nByr...
What did we do and find? Summarized in this thread:
authors.elsevier.com/a/1kFtR8nByr...
What did we do and find? Summarized in this thread:
🎯🎯LiverPRO🎯🎯
Another benchmark for non-invasive risk assessment for chronic liver disease in the primary care (but maybe not only there?) ▶️ LancetGH @robbrierley.bsky.social ky.social
www.thelancet.com/journals/lan...
Congrats Katrine Lindvig, Maja Thiele & team!
#GastroSky #LiverSky #MedSky
Another benchmark for non-invasive risk assessment for chronic liver disease in the primary care (but maybe not only there?) ▶️ LancetGH @robbrierley.bsky.social ky.social
www.thelancet.com/journals/lan...
Congrats Katrine Lindvig, Maja Thiele & team!
#GastroSky #LiverSky #MedSky
Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study
LiverPRO reliably identifies clinically significant liver fibrosis and elevated liver stiffness, predicts the risk of liver-related events in primary care, and is adaptable to the availability of different liver blood test analytes. On the basis of these results LiverPRO was certified according to IVDR class b, obtaining European CE approval in 2024.
www.thelancet.com
December 12, 2024 at 7:05 PM
🎯🎯LiverPRO🎯🎯
Another benchmark for non-invasive risk assessment for chronic liver disease in the primary care (but maybe not only there?) ▶️ LancetGH @robbrierley.bsky.social ky.social
www.thelancet.com/journals/lan...
Congrats Katrine Lindvig, Maja Thiele & team!
#GastroSky #LiverSky #MedSky
Another benchmark for non-invasive risk assessment for chronic liver disease in the primary care (but maybe not only there?) ▶️ LancetGH @robbrierley.bsky.social ky.social
www.thelancet.com/journals/lan...
Congrats Katrine Lindvig, Maja Thiele & team!
#GastroSky #LiverSky #MedSky
Very grateful to have received the Award of Excellence from the Austrian Ministry of Education, Sience and Resarch for my PhD thesis on "Non-invasive risk stratification in chronic liver disease".
Non-invasive liver disease assessment = the future 🚀
@Medical University of Vienna
shorturl.at/Q1Aos
Non-invasive liver disease assessment = the future 🚀
@Medical University of Vienna
shorturl.at/Q1Aos
December 12, 2024 at 6:38 PM
Very grateful to have received the Award of Excellence from the Austrian Ministry of Education, Sience and Resarch for my PhD thesis on "Non-invasive risk stratification in chronic liver disease".
Non-invasive liver disease assessment = the future 🚀
@Medical University of Vienna
shorturl.at/Q1Aos
Non-invasive liver disease assessment = the future 🚀
@Medical University of Vienna
shorturl.at/Q1Aos
Reposted by Georg Semmler
#LiverSky
Useful tip...
There's no 'bookmark' function in Bluesky currently. But there is a nice work-around:
1) Reply to the post of interest with a📌emoji
2) Click on this link bsky.app/profile/did:...
3) Click 'Pin to Home'
This will collate📌posts in a tab on your home screen + ⬆️ engagement.
Useful tip...
There's no 'bookmark' function in Bluesky currently. But there is a nice work-around:
1) Reply to the post of interest with a📌emoji
2) Click on this link bsky.app/profile/did:...
3) Click 'Pin to Home'
This will collate📌posts in a tab on your home screen + ⬆️ engagement.
November 26, 2024 at 12:11 PM
#LiverSky
Useful tip...
There's no 'bookmark' function in Bluesky currently. But there is a nice work-around:
1) Reply to the post of interest with a📌emoji
2) Click on this link bsky.app/profile/did:...
3) Click 'Pin to Home'
This will collate📌posts in a tab on your home screen + ⬆️ engagement.
Useful tip...
There's no 'bookmark' function in Bluesky currently. But there is a nice work-around:
1) Reply to the post of interest with a📌emoji
2) Click on this link bsky.app/profile/did:...
3) Click 'Pin to Home'
This will collate📌posts in a tab on your home screen + ⬆️ engagement.